Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil and propofol in electroconvulsive therapy for acute mania
IRCT138810082935N1Phase 2Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Mar 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of remifentanil and propofol in bipolar I disorder, sponsored by Kurdistan University of Medical Sciences. Started Mar 2010; status: completed.
02
Drugs
remifentanilpropofol
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on IRCT138810082935N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138810082935N1.